ReCode Therapeutics is a clinical-stage company that focuses on developing genetic medicines through precision delivery using its proprietary SORT lipid nanoparticle platform. This innovative technology enables targeted mRNA and gene correction therapies for conditions like primary ciliary dyskinesia and cystic fibrosis, with plans to address a wider array of genetic diseases.
No jobs found. Subscribe below to get notified when we find something for you.
Searching